APA (7th ed.) Citation

HS, K., JY, K., JY, L., B, S., JE, C., & YS, C. (2025). Directly reprogrammed NK cells driven by BCL11B depletion enhance targeted immunotherapy against pancreatic ductal adenocarcinoma. Journal of hematology & oncology, 18(1), 100. https://doi.org/10.1186/s13045-025-01730-1

Chicago Style (17th ed.) Citation

HS, Kim, Kim JY, Lee JY, Seol B, Choi JE, and Cho YS. "Directly Reprogrammed NK Cells Driven by BCL11B Depletion Enhance Targeted Immunotherapy Against Pancreatic Ductal Adenocarcinoma." Journal of Hematology & Oncology 18, no. 1 (2025): 100. https://doi.org/10.1186/s13045-025-01730-1.

MLA (9th ed.) Citation

HS, Kim, et al. "Directly Reprogrammed NK Cells Driven by BCL11B Depletion Enhance Targeted Immunotherapy Against Pancreatic Ductal Adenocarcinoma." Journal of Hematology & Oncology, vol. 18, no. 1, 2025, p. 100, https://doi.org/10.1186/s13045-025-01730-1.